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Speed et al., page 1011
The use of SNP-based genotyping for estimating herita-
bility in unrelated individuals has garnered significant
interest recently as a way to help explain the ‘‘missing heri-
tability’’ of many phenotypes. Many believe that ‘‘missing
heritability’’ can be found in either rare variants with
modest effects or common variants with weak effects. For
evaluating the idea that many common variants with
weak effects contribute to a complex phenotype, SNP-
based mixed-model analysis is widely used. In this paper,
Speed et al. use several simulations to find that, although
this method is very robust to perturbations in some under-
lying assumptions, it is highly sensitive to linkage disequi-
librium (LD). For example, estimated heritability can be
too low for low-frequency causal variants in low-LD
regions and too high for high-frequency variants in high-
LD regions. To correct for this bias, the authors developed
Linkage-Disequilibrium-Adjusted Kinship (LDAK), a soft-
ware program that modifies the kinship matrix for local
patterns of LD by equalizing the level of SNP tagging on
the basis of how well a SNP tags its neighbor. With the
use of data from the Wellcome Trust Case Control
Consortium and LDAK, heritability estimates were better
for several traits. The estimates improved by approxi-
mately 25% for hypertension and type 2 diabetes, suggest-
ing that the causal variants are not well tagged for these
diseases. Conversely, the estimation of heritability was
reduced for diseases caused by well-tagged variants in
high LD, e.g., rheumatoid arthritis and type 1 diabetes,
which are both associated with variants in themajor-histo-
compatibility-complex region. The incorporation of LDAK
should improve SNP-based genomic partitioning methods
currently in use and might also accelerate association anal-
ysis and phenotype prediction.Cycles of Variation
Koren et al., page 1033
The amount of human genetic diversity is immense, and
we are just now beginning to understand how and when
changes arise. The need for cells—both germ and
somatic—to replicate their DNA and divide provides
numerous opportunities for errors to be introduced into
the genome. The introduction of errors is not random;1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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The Americanprevious work has shown that early-replicating genomic
areas, where most protein-coding genes lie, accumulate
fewer mutations than do early-replicating regions. In this
issue, Koren et al. extend these analyses and provide an
in-depth view of the intersection between human genome
replication, mutation, and recombination. Notably, the
authors show that transversion and transition mutations
are the most prevalent mutation type at late-replicating
loci. Further work will be needed for identifying the mech-
anisms by which this type of biochemical specificity is
achieved; indeed, this study highlights the need for
cross-disciplinary collaboration in tackling tough biolog-
ical problems. The authors also show that recombination
and replication timing are more tightly associated in males
than in females. The underlying cause for this difference
remains unknown and will probably require technological
innovation so that it is addressed properly, but for now,
many interesting thought experiments will occupy the
readers’ minds.Are They Really Pathogenic?
Xue et al., page 1022
Accurate annotation of disease-causing mutations (DMs)
in databases such as the Human Gene Mutation Database
(HGMD) is imperative for the development of personalized
medicine and diagnosis of genetic disease. When faced
with a lack of additional evidence, investigators must
carefully interpret variant pathogenicity when evaluating
missense alleles that are predicted to be damaging.
In this study, Xue et el. analyzed 1000 Genomes Pilot
Project sequence to estimate the average number of
predicted harmful missense mutations in healthy individ-
uals and to compare these variants to DMs annotated
in HGMD. Their work shows that healthy individuals
can harbor 281–515 missense substitutions (40–85 of
which are homozygous) that are predicted to be damaging.
On average, each individual had 40–110 heterozygous
variants and 3–24 homozygous variants that are annotated
in HGMD as being DMs. Further analysis of 71 DMs
suggested that 3 are functional polymorphisms and
22 are not pathogenic, although reduced penetrance
might explain the lack of phenotype in some cases. With
the increasing number and diversity of genomes being
sequenced, the identification of variants predicted as
being DMs in healthy populations could prompt they of Human Genetics. All rights reserved.
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continual refining of annotations in databases such as
HGMD. Although cumbersome, persistent curation of
these databases will no doubt improve genetic testing
and treatment.New Insights into HSPs
Oz-Levi et al., page 1065; Tesson et al., page 1051;
Schuurs-Hoeijmakers et al., page 1122
Hereditary spastic paraplegias (HSPs) are one of the most
heterogeneous groups of inherited disease. Characterized
by progressive spasticity of the lower limbs, HSPs can be
further divided by the presence or absence of additional
neurological and/or extraneurological phenotypes. The
era of exome sequencing has enabled the molecular diag-
noses of many previously uncharacterized forms of HSP,
and this issue contains three additional reports of muta-
tions that lead to HSP. Although the mutations lie in
different genes, together, the papers highlight the
interconnected nature of the genetic defects that underlie
these complex disorders. By identifying a mutation in
TECPR2, Oz-Levi et al. reveal a connection between HSPs
and autophagy. Tesson et al. and Schuurs-Hoeijmakers
et al. identify in two intracellular phospholipases A1 family
members, DDHD1 and DDHD2, mutations causing HSP
subtypes that are linked by the presence of defects in
lipid metabolism. Moreover, Tesson et al. also show that
mutations in CYP2U1, which encodes a cytochrome
P450 enzyme, cause a distinct form of HSP. Taken together,
these papers uncover the importance of fatty-acid and
phospholipid metabolism in neurological health. The
connections revealed in these papers suggest that addi-
tional HSPs, as well as other neurological disorders, are974 The American Journal of Human Genetics 91, 973–974, Decembcaused by disruptions in this vast network of cellular meta-
bolic control.lincing RNA to Human Disease
Talkowski et al., page 1128
Recent years have seen great advances in the under-
standing of how gene mutations and disruptions cause
human disease. Yet, as we all know, protein-coding
sequences constitute just a small portion of the genome.
Until whole-genome sequencing becomes commonplace,
our comprehension of how the remaining portions of
the genome contribute to disease will probably lag behind.
In this issue, Talkowski et al. provide a glimpse of the
insights that we might hope to glean in the coming years.
They first identified an individual who is affected by
a neurodevelopmental abnormality and who harbors a
balanced chromosomal translocation only disrupting
LINC00299, a gene whose RNA product is a large intergenic
noncoding RNA (lincRNA). Follow-up work identified
copy-number variants affecting LINC00299 in several indi-
viduals with neurodevelopmental phenotypes. Interest-
ingly, LINC00299 expression levels increase during the
course of neural-progenitor differentiation, thus providing
some insight into the biology that underlies these clinical
manifestations. lincRNAs, a newly identified class of RNA,
are thought to regulate gene transcription, but the number
of characterized family members remains low. In pointing
to a role for a lincRNA in human neurodevelopment, this
study highlights just how little we know about the genome
and provides hints of exciting findings that will no doubt
be made in the quest for understanding the molecular
bases of human disease.er 7, 2012
